130 Characterizing ocular adverse events in clinical trials of GLP-1 drugs using weighted and unweighted participant counts results reported on ClinicalTrials.gov
Roberta Bruhn, Katie Steimel, Christina Barone · 2026
Read 130 Characterizing ocular adverse events in clinical trials of GLP-1 drugs using weighted and unweighted participant counts results reported on ClinicalTrials.gov by Roberta Bruhn, Katie Steimel, Christina Barone (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13173234.txt.
Description
Eye side effects have been tied to a popular class of diabetes and weight drugs, and trial registries hold clues to their scale. Roberta Bruhn, Katie Steimel, and Christina Barone mined those registries in a 2026 conference report. Their search found over fifteen hundred trials of the drug class, cut to those finished with results posted. Sixty-four studies reported eye events of some kind.
Eye events ranked tenth among body systems hit in these trials. The team summed event shares by drug arm and by how serious the events were, in two counting styles. Standard tests checked whether shares differed across arms. Study traits were folded into the models as well. The report maps how often eye harm shows up in this drug class's trials.
Catalog record
| CREATOR | Roberta Bruhn, Katie Steimel, Christina Barone |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |